MHRA

Britain has become the first country in the world to approve a bivalent vaccine against COVID-19, which "works" simultaneously against the original and the current version of the Omicron coronavirus.

Reports in German media outlets that the Oxford-AstraZeneca COVID-19 vaccine is less effective in older people appear to be unfounded, the German government said Tuesday.

UK and Russian scientists are teaming up to trial a combination of the Oxford-AstraZeneca and Sputnik V vaccines to see if protection against Covid-19 can be improved.

Mixing two similar vaccines could lead to a better immune response in people.

The trials, to be held in Russia, will involve over-18s, although it's not clear how many people will be involved.

Britain's medicine regulator has advised that people with a history of significant allergies do not get Pfizer-BioNTech's COVID-19 vaccine after two people reported severe adverse reactions on the first day of rollout.

According to the BBC, the British regulator MHRA announced that the vaccine, which according to the latest data has an efficiency of 95% in protection against COVID-19, is safe for distribution.
The media states that immunization of priority groups of people could start in a few days.